Pharmaceuticals and Public Health

JAMA. 2016 Nov 22;316(20):2083-2084. doi: 10.1001/jama.2016.15397.
No abstract available

MeSH terms

  • Antiviral Agents / economics
  • Cost Control
  • Drug Costs*
  • Drug Industry / economics*
  • Federal Government
  • Group Purchasing
  • Hepatitis C / drug therapy
  • Humans
  • Public Health*
  • United States

Substances

  • Antiviral Agents